Skip to main content

4 articles related to "Cyclovirobuxine D"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Accepted on 27 Feb 2026

Cyclovirobuxine D suppresses cancer stemness in osteosarcoma with implication of the noncanonical NF-kappaB pathway

in Pharmacology of Anti-Cancer Drugs

Jinku Guo
Yingfeng Cao
Kaipeng Jin
Bing Liu
Wei Wang
Chen Chen
Jun Xie
Ankai Xu

Frontiers in Pharmacology

Original Research

Published on 19 Mar 2021

Cyclovirobuxine D Induces Apoptosis and Mitochondrial Damage in Glioblastoma Cells Through ROS-Mediated Mitochondrial Translocation of Cofilin

in Pharmacology of Anti-Cancer Drugs

Lin Zhang
Ruoqiu Fu
Dongyu Duan
Ziwei Li
Bin Li
Yue Ming
Li Li
Rui Ni
Jianhong Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.656184

6,214 views
20 citations

Original Research

Published on 05 Jul 2022

Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis via NLRP3 in vivo and in vitro

in Cardiovascular and Smooth Muscle Pharmacology

Ge Gao
Lingyun Fu
Yini Xu
Ling Tao
Ting Guo
Guanqin Fang
Guangqiong Zhang
Shengquan Wang
Ti Qin
Peng Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.906548

6,992 views
35 citations

Original Research

Published on 21 Dec 2022

Cyclovirobuxine D, a cardiovascular drug from traditional Chinese medicine, alleviates inflammatory and neuropathic pain mainly via inhibition of voltage-gated Cav3.2 channels

in Pharmacology of Ion Channels and Channelopathies

Deyuan Su
Ye Gong
Songyu Li
Jian Yang
Yin Nian

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1081697

6,578 views
16 citations